Barclays
CLPT icon

Barclays’s ClearPoint Neuro CLPT Stock Holding History

Barclays’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
7,362
-6,873
-48% -$85.8K ﹤0.01% 3926
2026
Q1 		$130K Sell
14,235
-33,078
-70% -$418K ﹤0.01% 3918
2025
Q4 		$647K Buy
47,313
+9,053
+24% +$168K ﹤0.01% 3707
2025
Q3 		$834K Sell
38,260
-9,128
-19% -$108K ﹤0.01% 3479
2025
Q2 		$566K Sell
47,388
-2,528
-5% -$31.8K ﹤0.01% 3697
2025
Q1 		$594K Sell
49,916
-16,520
-25% -$257K ﹤0.01% 3418
2024
Q4 		$1.02M Buy
66,436
+60,762
+1,071% +$787K ﹤0.01% 3368
2024
Q3 		$63.6K Buy
5,674
+1,109
+24% +$10.6K ﹤0.01% 4692
2024
Q2 		$24.6K Sell
4,565
-11,594
-72% -$67.1K ﹤0.01% 4408
2024
Q1 		$110K Sell
16,159
-15,365
-49% -$107K ﹤0.01% 4399
2023
Q4 		$214K Buy
31,524
+27,417
+668% +$155K ﹤0.01% 4388
2023
Q3 		$20.6K Sell
4,107
-487
-11% -$2.9K ﹤0.01% 4175
2023
Q2 		$33.3K Sell
4,594
-7,225
-61% -$61.5K ﹤0.01% 4003
2023
Q1 		$99.8K Sell
11,819
-1,710
-13% -$15K ﹤0.01% 4180
2022
Q4 		$115K Buy
13,529
+12,781
+1,709% +$121K ﹤0.01% 4148
2022
Q3 		$8K Buy
+748
New +$9.86K ﹤0.01% 4381
2022
Q2 		– Sell
-3,093
Closed -$32K – 5051
2022
Q1 		$32K Buy
+3,093
New +$28.2K ﹤0.01% 4285

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Barclays's CLPT Position: Q2 2026 in Review

Barclays reduced its ClearPoint Neuro (CLPT) stake by 48% in Q2 2026, selling an estimated $85.8K and leaving 7,362 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #3926.

Barclays first reported a position in CLPT in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.02M in Q4 2024. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Barclays held 7,362 shares of ClearPoint Neuro worth $131K as of Q2 2026.
  • Barclays sold 6,873 ClearPoint Neuro shares in Q2 2026, an estimated $85.8K.
  • ClearPoint Neuro made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3926 holding.
  • Barclays first reported a position in ClearPoint Neuro in Q1 2022 and has held it in 17 quarters since.
  • Barclays's ClearPoint Neuro position peaked at $1.02M in Q4 2024.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.